Baidu Inc (ADR) (NASDAQ:BIDU) caters to the Technology space. It has a net profit margin of 19.70% and weekly performance is -9.36%. On the last day of trading company shares ended up at $171.34. Baidu Inc (ADR) (NASDAQ:BIDU) distance from 50-day simple moving average (SMA50) is -3.12%.
Baidu Inc (ADR) (NASDAQ:BIDU) said that, it is looking to ramp up its takeout delivery business and is seeking a sum of between $300-$500 million to do so. Yesterday we reported on Alibaba’s $1.25 billion investment in the food delivery application Ele.me, mentioning that both Baidu Inc (ADR) (NASDAQ:BIDU) and Alibaba had interest in this rapidly growing business within the nation of China.
Star Bulk Carriers Corp. (NASDAQ:SBLK) ended the last trading day at $0.44. Company weekly volatility is calculated as 20.35% and price to cash ratio as 0.41. Star Bulk Carriers Corp. (NASDAQ:SBLK) showed a weekly performance of -27.87%.
Star Bulk Carriers Corp. (NASDAQ:SBLK) announced that the Company received a letter from the Listing Qualifications department of The NASDAQ Stock Market LLC (“Nasdaq”), dated as of January 6, 2016, notifying the Company that the minimum bid price for its common shares was below $1.00 per share for a period of 30 consecutive business days, and that the Company therefore did not meet the minimum bid price requirement for the Nasdaq Global Select Market, which is set forth in Nasdaq Listing Rule 5450(a)(1).
On 08 January, Hologic Inc. (NASDAQ:HOLX) shares decreased -2.19% and was closed at $36.55. HOLX EPS growth in last 5 year was 31.10%. Hologic Inc. (NASDAQ:HOLX) year to date (YTD) performance is -5.53%.
On 6 January, Hologic Inc. (NASDAQ:HOLX) said that, it struck a deal with cancer diagnostics company Metamark Genetics to market its prostate cancer test. Cepheid announced that it’s teaming up with Henry Schein Medical to distribute its testing system and related diagnostics, which cover areas including infectious disease and sexual health.
Kite Pharma, Inc. (NASDAQ:KITE) shares decreased -0.88% in last trading session and ended the day at $54.15. KITE has a return on assets of -20.60%. Kite Pharma, Inc. (NASDAQ:KITE) quarterly performance is -14.14%.
On 7 January, Kite Pharma, Inc. (NASDAQ:KITE) announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI for the research and clinical development of a fully human anti-CD19 chimeric antigen receptor (CAR) product candidate for the treatment of B-cell lymphomas and leukemias. Under the CRADA, Kite will collaborate with James (Jim) N. Kochenderfer, M.D., an investigator in the Experimental Transplantation and Immunology Branch of the NCI, to evaluate this product candidate in a Phase 1 clinical study this year.
MeetMe, Inc. (NASDAQ:MEET) caters to the Technology space. It has a net profit margin of 1.40% and weekly performance is 21.23%. On the last day of trading company shares ended up at $4.34. MeetMe, Inc. (NASDAQ:MEET) distance from 50-day simple moving average (SMA50) is -7.27%.
On 6 Januray, MeetMe, Inc. (NASDAQ:MEET) raised its full year 2015 financial guidance for the year ended December 31, 2015 in advance of a non-deal roadshow with potential investors. Total revenue is expected to be approximately $56.5 million, an increase of 26% from full year 2014, and above the Company’s previously released guidance range of $53.5 million to $54 million for full year 2015.
Leave a Reply